Klaus Bønnelykke is a PHD and MD with training in pediatrics. His research is based on the COpenhagen Prospective Studies on Asthma in Childhood (COPSAC) research center where he has worked several years as a senior researcher. His research area can be described as clinical translational research combining clinical data from birth cohort studies with basic research methodologies. The focus is early origins and functional subtypes (endotypes) of asthma, allergy and eczema with a particular emphasis on genetics. This has resulted in novel discoveries of susceptibility genes and other risk factors for asthma, eczema and allergy. He has authored or co-authored more than 70 peer-reviewed articles in international medical journals.
He has been the recipient of a number of awards including the Lundbeck Foundation Fellowship (2014), the Klosterfrau Research Award for Outstanding Research in Pediatric Pulmonology (2014), the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology (2014), and a Best Presentation Award at the European Academy of Allergology and Clinical Immunology congress (2014).